O’Hagan, Derek T.

Nonviral delivery of self-amplifying RNA vaccines

Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 675

Mechanism of action of mRNA-based vaccines

Iavarone, C., O’hagan, D. T., Yu, D., Delahaye, N. F., & Ulmer, J. B. (2017) · Expert Review of Vaccines

Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Cited by 234

Microparticles as vaccine adjuvants and delivery systems

O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines

Immunotherapy and Immune ResponsesAdvanced Drug Delivery Systems

Cited by 214

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Walls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 185

Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines

Goswami, R., Chatzikleanthous, D., Lou, G., Giusti, F., Bonci, A., Taccone, M., Brazzoli, M., Gallorini, S., Ferlenghi, I., Berti, F., et al. (2019) · ACS Infectious Diseases

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 113